Atara bio stock
Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis. Latest Stock Picks Atara Biotherapeutics and Exelixis might be top takeover targets for the biotech giant. ATRA Stock Price, Forecast & News (Atara Biotherapeutics) Atara Biotherapeutics' stock was trading at $9.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ATRA stock has decreased by 24.4% and is now trading at $7.53. ATRA:NASDAQ GS Stock Quote - Atara Biotherapeutics Inc ...
Atara Biotherapeutics Prices IPO Below The Range At $11 A ...
Mar 12, 2018 · After its lead programs had failed, Atara Bio used to be a forgotten stock.Some of you maybe remember my first article on the company "Stock Up, Business Shrinking."Indeed, Stock To Watch: Atara Biotherapeutics (ATRA) | Nasdaq Feb 11, 2020 · (RTTNews) - Atara Biotherapeutics Inc. (ATRA) has some key milestones lined up for this year, making it a stock worth watching. Atara is focused on developing off-the-shelf, allogeneic T-cell Stock Information | Atara Biotherapeutics The Investor Relations website contains information about Atara Biotherapeutics's business for stockholders, potential investors, and financial analysts. Atara Biotherapeutics, Inc. (ATRA) Stock Major Holders ... Find out the direct holders, institutional holders and mutual fund holders for Atara Biotherapeutics, Inc. (ATRA).
Currently, the analyst consensus on Atara Biotherapeutics is a Strong Buy with an average price target of $56.50, which is a 280.5% upside from current levels. In a report released today, Mizuho Securities also maintained a Buy rating on the stock with a $43.00 price target. Globus Medical (GMED)
(RTTNews) - Atara Biotherapeutics Inc. (ATRA) has some key milestones lined up for this year, making it a stock worth watching. Atara is focused on developing off-the-shelf, allogeneic T-cell Atara Biotherapeutics | LinkedIn Atara Biotherapeutics, Inc. (Nasdaq: ATRA) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases
According to GuruFocus Real-Time Picks, a Premium feature, Klarman divested of 842,212 shares of the Boston-based biotech company on Nov. 30. Seth
Atara Biotherapeutics Reviews | Glassdoor Pros. Working at Atara is very rewarding! You are empowered everyday to make a positive impact on your team and those surrounding you. From frequent employee events to lunch-and-learns from industry experts, Atara is focused on keeping employees engaged and working towards the same goal.
ATRA News Today (Atara Biotherapeutics) | MarketBeat
ATRA:NASDAQ GS Stock Quote - Atara Biotherapeutics Inc ... Stock analysis for Atara Biotherapeutics Inc (ATRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Working at Atara Biotherapeutics | Glassdoor Glassdoor gives you an inside look at what it's like to work at Atara Biotherapeutics, including salaries, reviews, office photos, and more. This is the Atara Biotherapeutics company profile. All content is posted anonymously by employees working at Atara Biotherapeutics.
ATRA - Atara Biotherap Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Atara Biotherapeutics (NasdaqGS:ATRA) - Share price, News ...